Sikarin Public Company Limited (SKR.BK)
- Previous Close
6.70 - Open
6.70 - Bid --
- Ask --
- Day's Range
6.60 - 6.75 - 52 Week Range
6.55 - 10.50 - Volume
551,251 - Avg. Volume
250,500 - Market Cap (intraday)
13.885B - Beta (5Y Monthly) --
- PE Ratio (TTM)
22.50 - EPS (TTM)
0.30 - Earnings Date --
- Forward Dividend & Yield 0.22 (3.26%)
- Ex-Dividend Date Apr 29, 2025
- 1y Target Est
--
Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. The company operates diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, children's dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis units, physical therapy department with physical medicine and rehabilitation specialist, catheter laboratory, intensive care units, coronary care units, inpatient wards and international wards, after heart and thoracic surgery ward, medical-surgical ward, and pediatric ward. It also operates woman's health center, health center, fertility center, delivery room, nursery department and the inpatient wards, obstetrics and gynecology ward, stroke center, EENT center, international medical center, orthopedics center, and MRI center. In addition, the company is involved in the management of rental spaces; and sale of food and beverages, as well as restaurant and medical clinic business. Sikarin Public Company Limited was founded in 1979 and is headquartered in Bangkok, Thailand.
www.sikarin.com3,173
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SKR.BK
View MorePerformance Overview: SKR.BK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SKR.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SKR.BK
View MoreValuation Measures
Market Cap
13.89B
Enterprise Value
13.18B
Trailing P/E
22.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.30
Price/Book (mrq)
1.77
Enterprise Value/Revenue
2.18
Enterprise Value/EBITDA
9.41
Financial Highlights
Profitability and Income Statement
Profit Margin
10.43%
Return on Assets (ttm)
5.41%
Return on Equity (ttm)
8.12%
Revenue (ttm)
6.07B
Net Income Avi to Common (ttm)
632.88M
Diluted EPS (ttm)
0.30
Balance Sheet and Cash Flow
Total Cash (mrq)
1.05B
Total Debt/Equity (mrq)
9.76%
Levered Free Cash Flow (ttm)
388.12M